|
Index of reports
> Cases with Cardio-Respiratory Arrest ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Risperdal (Risperidone) where reactions include cardio-respiratory arrest. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Risperdal side effects in 18 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-20
Patient: 18 year old male
Reactions: Cardio-Respiratory Arrest, Coma, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Lepticur
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2000-12-06
End date: 2000-12-06
Clonazepam
Administration route: Oral
Start date: 2000-12-07
Clopixol
Start date: 2000-12-07
End date: 2000-12-07
Clonazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2000-12-06
End date: 2000-12-06
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2000-12-07
End date: 2000-12-07
Risperdal
Administration route: Oral
Start date: 2000-12-08
End date: 2000-12-09
Clopixol
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2000-12-11
Lepticur
Administration route: Oral
Start date: 2000-12-07
End date: 2000-12-07
Tercian
Indication: Product Used FOR Unknown Indication
Start date: 2000-12-06
End date: 2000-12-06
Nozinan
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2000-12-10
Nozinan
Start date: 2000-12-08
End date: 2000-12-10
Possible Risperdal side effects in 76 year old female
Reported by a physician from Japan on 2012-05-30
Patient: 76 year old female, weighing 53.0 kg (116.6 pounds)
Reactions: Pulmonary Haemorrhage, Cardio-Respiratory Arrest, Respiratory Failure, Pulmonary Embolism, Neuroleptic Malignant Syndrome, Deep Vein Thrombosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Risperdal
Dosage: 3-10 mg/day
Administration route: Oral
Start date: 2003-10-16
End date: 2011-06-20
Risperdal
Dosage: 3-10 mg/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2003-10-16
End date: 2011-06-20
Other drugs received by patient: Cibenol; Parlodel; Rohypnol; Lonasen
Possible Risperdal side effects in female
Reported by a physician from Japan on 2012-03-02
Patient: female
Reactions: Cardio-Respiratory Arrest, Sepsis, Postresuscitation Encephalopathy, Multiple Drug Overdose, Ileus Paralytic
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Seroquel
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-19
End date: 2007-06-28
Nitrazepam
Administration route: Oral
Indication: Insomnia
Clarithromycin
Administration route: Oral
Indication: Pneumonia
Start date: 2007-06-22
End date: 2007-06-28
Depas
Seroquel
Administration route: Oral
Tegretol
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-20
End date: 2007-06-28
Tolopelon
Indication: Schizophrenia
Start date: 2007-06-19
End date: 2007-06-28
Rilmazafone Hydrochloride
Administration route: Oral
Haloperidol
Indication: Schizophrenia
Start date: 2007-06-20
End date: 2007-06-28
Risperdal
Administration route: Oral
Start date: 2007-06-19
End date: 2007-06-28
Phenobarbital TAB
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-20
End date: 2007-06-28
Akineton
Zyprexa
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-19
End date: 2007-06-28
Promethazine HCL
Administration route: Oral
Indication: Schizophrenia
Doral
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-27
End date: 2007-06-28
Risperdal
Administration route: Oral
Indication: Schizophrenia
Promazine Hydrochloride
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-23
End date: 2007-06-28
Nitrazepam
Administration route: Oral
Start date: 2007-06-27
End date: 2007-06-28
Sofmin Amel
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-19
End date: 2007-06-28
Lodopin
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-25
End date: 2007-06-28
Promethazine HCL
Administration route: Oral
Start date: 2007-06-19
End date: 2007-06-28
Valproic Acid
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-25
End date: 2007-06-28
Luvox
Alprazolam
Indication: Anxiety
Celmanil
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-19
End date: 2007-06-28
Levotomin
Start date: 2007-06-19
End date: 2007-06-28
Slowheim
Administration route: Oral
Indication: Schizophrenia
Slowheim
Administration route: Oral
Start date: 2007-06-27
End date: 2007-06-28
Levotomin
Indication: Schizophrenia
Other drugs received by patient: Sennoside; Pantosin; Laxoberon; Magnesium Sulfate; Mucotron
Possible Risperdal side effects in female
Reported by a physician from Japan on 2011-12-27
Patient: female
Reactions: Cardio-Respiratory Arrest, Sepsis, Postresuscitation Encephalopathy, Multiple Drug Overdose, Ileus Paralytic
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Luvox
Seroquel
Administration route: Oral
Haloperidol
Indication: Schizophrenia
Start date: 2007-06-20
End date: 2007-06-28
Doral
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-27
End date: 2007-06-28
Seroquel
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-19
End date: 2007-06-28
Celmanil
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-19
End date: 2007-06-28
Promethazine HCL
Administration route: Oral
Start date: 2007-06-19
End date: 2007-06-28
Valproic Acid
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-25
End date: 2007-06-28
Pantosin
Administration route: Oral
Indication: Constipation
Start date: 2007-06-26
Akineton
Nitrazepam
Administration route: Oral
Indication: Insomnia
Slowheim
Administration route: Oral
Start date: 2007-06-27
End date: 2007-06-28
Levotomin
Indication: Schizophrenia
Risperdal
Administration route: Oral
Start date: 2007-06-19
End date: 2007-06-28
Zyprexa
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-19
End date: 2007-06-28
Tegretol
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-20
End date: 2007-06-28
Laxoberon
Administration route: Oral
Indication: Constipation
Start date: 2007-06-26
Lodopin
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-25
End date: 2007-06-28
Promethazine HCL
Administration route: Oral
Indication: Schizophrenia
Sofmin Amel
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-19
End date: 2007-06-28
Slowheim
Administration route: Oral
Indication: Schizophrenia
Tolopelon
Indication: Schizophrenia
Start date: 2007-06-19
End date: 2007-06-28
Mucotron
Administration route: Oral
Indication: Pneumonia
Start date: 2007-06-22
Rilmazafone Hydrochloride
Administration route: Oral
Depas
Risperdal
Administration route: Oral
Indication: Schizophrenia
Promazine Hydrochloride
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-23
End date: 2007-06-28
Phenobarbital TAB
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-20
End date: 2007-06-28
Nitrazepam
Administration route: Oral
Start date: 2007-06-27
End date: 2007-06-28
Clarithromycin
Administration route: Oral
Indication: Pneumonia
Start date: 2007-06-22
End date: 2007-06-28
Levotomin
Start date: 2007-06-19
End date: 2007-06-28
Alprazolam
Indication: Anxiety
Sennoside
Administration route: Oral
Indication: Constipation
Start date: 2007-06-26
Magnesium Sulfate
Administration route: Oral
Indication: Constipation
Start date: 2007-06-26
Possible Risperdal side effects in male
Reported by a physician from Japan on 2011-12-14
Patient: male, weighing 82.0 kg (180.4 pounds)
Reactions: Defaecation Urgency, Pneumonia, Blood Creatine Phosphokinase Increased, Nausea, Postresuscitation Encephalopathy, Abnormal Faeces, Intestinal Obstruction, Pyrexia, Respiratory Depression, Apallic Syndrome, Ileus Paralytic, Faeces Hard, Cardio-Respiratory Arrest, Intestinal Dilatation, Sepsis, Dizziness, Gastrointestinal Oedema
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Tegretol
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-20
End date: 2007-09-28
Risperdal
Dosage: 4 mg, unk
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-28
Nitrazepam
Dosage: 15 mg, unk
Administration route: Oral
Indication: Insomnia
Start date: 2007-06-28
Promethazine HCL
Dosage: 50 mg, unk
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-28
Clarithromycin
Dosage: 600 mg, unk
Administration route: Oral
Indication: Pneumonia
Start date: 2007-06-22
End date: 2007-07-28
Slowheim
Dosage: 15 mg, unk
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-28
Slowheim
Dosage: 10 mg, unk
Administration route: Oral
Lodopin
Dosage: 200 mg, unk
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-25
End date: 2007-06-28
Seroquel
Dosage: 100 mg, unk
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-28
Tolopelon
Dosage: 24 mg, unk
Indication: Schizophrenia
Start date: 2007-06-19
End date: 2007-06-28
Sofmin
Dosage: 60 mg, unk
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-19
End date: 2007-06-28
Nitrazepam
Dosage: 1 g, unk
Administration route: Oral
Zyprexa
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-19
End date: 2007-06-28
Valproic Acid
Dosage: 600 mg, unk
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-25
End date: 2007-06-28
Promazine Hydrochloride
Dosage: 150 mg, unk
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-23
End date: 2007-06-28
Phenobarbital TAB
Dosage: 80 mg, unk
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-20
End date: 2007-06-28
Celmanil
Haloperidol
Dosage: 30 mg, unk
Indication: Schizophrenia
Start date: 2007-06-20
End date: 2007-09-28
Risperdal
Dosage: 10 mg, unk
Administration route: Oral
Promethazine HCL
Dosage: 210 mg, unk
Administration route: Oral
Doral
Dosage: 20 mg, unk
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-27
End date: 2007-06-28
Levotomin
Dosage: 50 mg, unk
Indication: Schizophrenia
Start date: 2007-06-28
Other drugs received by patient: Laxoberon; Akineton; Sennoside; Magnesium Sulfate; Mucotron; Depas; Luvox; Pantosin; Rilmazafone; Alprazolam; Timiperone
Possible Risperdal side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-15
Patient: male, weighing 73.9 kg (162.7 pounds)
Reactions: Pneumonia, Congestive Cardiomyopathy, Mental Status Changes, Hepatic Failure, Loss of Consciousness, Hepatic Enzyme Increased, Renal Failure, Cardio-Respiratory Arrest, Respiratory Failure, Myocardial Infarction, Cardiac Failure Congestive
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Indication: Schizophrenia
Start date: 2009-02-23
End date: 2009-02-25
Ambien
Indication: Insomnia
Start date: 2009-02-23
End date: 2009-02-25
Other drugs received by patient: Seroquel; Seroquel
Possible Risperdal side effects in male
Reported by a physician from France on 2011-11-11
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Cardio-Respiratory Arrest, Epilepsy, Treatment Noncompliance, Aggression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Impulsive Behaviour
Start date: 2010-10-26
End date: 2010-12-27
Risperdal
Administration route: Oral
Indication: Aggression
Start date: 2010-10-26
End date: 2010-12-27
Keppra
Administration route: Oral
Indication: Epilepsy
Start date: 2010-10-01
End date: 2010-12-27
Risperdal
Administration route: Oral
Indication: Affective Disorder
Start date: 2010-10-26
End date: 2010-12-27
Possible Risperdal side effects in male
Reported by a consumer/non-health professional from United States on 2011-10-24
Patient: male, weighing 73.9 kg (162.7 pounds)
Reactions: Pneumonia, Mental Status Changes, Hepatic Failure, Congestive Cardiomyopathy, Loss of Consciousness, Hepatic Enzyme Increased, Renal Failure, Cardio-Respiratory Arrest, Respiratory Failure, Myocardial Infarction, Cardiac Failure Congestive
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Ambien
Indication: Insomnia
Start date: 2009-02-23
End date: 2009-02-25
Risperdal
Indication: Schizophrenia
Start date: 2009-02-23
End date: 2009-02-25
Other drugs received by patient: Seroquel; Seroquel
|
